Is It Too Late to Buy Johnson & Johnson Stock?

·5-min read
Is It Too Late to Buy Johnson & Johnson Stock?

Blue-chip pharmaceutical company Johnson & Johnson (NYSE: Johnson & Johnson) has seen its share of successes over the past 12 months. Johnson & Johnson responded swiftly to develop a COVID-19 vaccine, as did Pfizer, BioNTech SE, and Moderna. As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine had been administered in the U.S.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting